Stay informed with the latest litigation news. Explore now

IP Verse

Adare Pharmaceuticals competitive analysis

Latest publications and patents of Adare Pharmaceuticals New

Explore the latest publications and patents granted to Adare Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Adare Pharmaceuticals

EP3041476
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic EsophagitisPatent Maintained As Amended
EP2646003
Jun 3, 2020Rapidly Dispersing Granules, Orally Disintegrating Tablets And MethodsRevoked
EP3403654
Jul 31, 2019Orally Administered Corticosteroid CompositionsGranted And Under Opposition
EP2482822
Aug 1, 2018Orally Administered Corticosteroid CompositionsRevoked

Latest patents of Adare Pharmaceuticals opposed by its competitors

Explore Adare Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3041476
Jan 25, 2023Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis1
EP2646003
Jun 3, 2020Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods1
EP3403654
Jul 31, 2019Orally Administered Corticosteroid Compositions1
EP2482822
Aug 1, 2018Orally Administered Corticosteroid Compositions1

Latest PTAB cases involving Adare Pharmaceuticals New

Discover the latest PTAB cases involving Adare Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Top competitors of Adare Pharmaceuticals

Top competitors of Adare Pharmaceuticals based on patent oppositions.